Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system

被引:21
作者
Koshimura, I
Imai, H
Hidano, T
Endo, K
Mochizuki, H
Kondo, T
Mizuno, Y
机构
[1] Department of Neurology, Juntendo Univ. School of Medicine, Tokyo 113, 2-1-1 Hongo, Bunkyo-ku
关键词
Parkinson's disease; 3,4-dimethoxyphenylethylamine; tetrahydropapaverine; MPP+; dopamine; osmotic pump; tetrahydroisoquinoline;
D O I
10.1016/S0006-8993(97)00922-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We report the toxic effects of 3,4-dimethoxyphenylethylamine (DMPEA), and tetrahydropapaverine (THP) on the rat nigrostriatal system; THP is a tetrahydroisoquinoline compound which may be derived from DMPEA by conjugation of DMPEA and its oxidative metabolite, dimethoxyphenylacetaldehyde; both are potent inhibitors of mitochondrial complex I. These compounds were introduced to the unilateral caudate-putamen of male Sprague-Dawley rats over 7 days using a 200-mu l mini-osmotic pump. Striatal dopamine on the injected side showed a significant decrease to 86% of the non-injected side after 16.55 mu mol/7 days infusion of DMPEA, and to 73% of the non-injected side after 7.90 mu mol/7 days of THP infusion; as the non-injected side dopamine also reduced in the THP-injected rats, dopamine on the injected side was 55% of the saline control. Tyrosine hydroxylase (TH)-positive nigral neurons were decreased to 76% of the non-injected side after 16.55 mu mol/7 days infusion of DMPEA and to 77% after 7.90 mu mol/7 days of THP infusion. Dimethoxyphenyl-tetrahydroisoquinoline compounds appear to be potent nigral neurotoxins. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:108 / 116
页数:9
相关论文
共 62 条
[1]  
BARBEAU A, 1965, REV CAN BIOL EXPTL, V24, P229
[2]   EFFECT OF 3,4-DIMETHOXYPHENYLETHYLAMINE INJECTIONS UPON DOPAMINE METABOLISM IN RATS AND DOGS [J].
BARBEAU, A ;
LESCOP, J ;
DUPLESSIS, P ;
ELIE, R .
EXPERIENTIA, 1967, 23 (07) :536-+
[3]   PHARMACOLOGY OF AKINESIA - INVESTIGATIONS ON 3,4-DIMETHOXYPHENYLETHYLAMINE [J].
BARBEAU, A ;
TETREAULT, L ;
OLIVA, L ;
MORAZAIN, L ;
CARDIN, L .
NATURE, 1966, 209 (5024) :719-+
[4]  
BARBEAU ANDRE, 1963, REV CANADIENNE BIOL, V22, P469
[5]  
BARBEAU ANDRE, 1966, LIFE SCI, V5, P757, DOI 10.1016/0024-3205(66)90216-5
[6]   ETIOLOGY OF PARKINSONS-DISEASE [J].
CALNE, DB ;
LANGSTON, JW .
LANCET, 1983, 2 (8365) :1457-1459
[7]   INTRACEREBROVENTRICULAR ADMINISTRATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) AND ITS METABOLITE 1-METHYL-4-PHENYLPYRIDINIUM ION (MPP+) DECREASE DOPAMINE AND INCREASE ACETYLCHOLINE IN THE MOUSE NEOSTRIATUM [J].
CAVALLA, D ;
HADJICONSTANTINOU, M ;
LAIRD, HE ;
NEFF, NH .
NEUROPHARMACOLOGY, 1985, 24 (06) :585-586
[8]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[9]   ACTIVE UPTAKE OF MPP+, A METABOLITE OF MPTP, BY BRAIN SYNAPTOSOMES [J].
CHIBA, K ;
TREVOR, AJ ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 128 (03) :1228-1232
[10]   BETA-CARBOLINE ANALOGS OF N-METHYL-4-PHENYL-1,2,5,6-TETRA-HYDROPYRIDINE (MPTP) - ENDOGENOUS FACTORS UNDERLYING IDIOPATHIC PARKINSONISM [J].
COLLINS, MA ;
NEAFSEY, EJ .
NEUROSCIENCE LETTERS, 1985, 55 (02) :179-184